Lv4
430 积分 2023-12-19 加入
Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B
10个月前
已完结
Occurence of hepatocellular carcinoma in chronic hepatitis B patients undergoing entecavir or tenofovir treatment: a multicenter study in Taiwan
10个月前
已关闭
Comparison of the on‐treatment risks for hepatocellular carcinoma between entecavir and tenofovir: A propensity score matching analysis
10个月前
已完结
Tenofovir Versus Entecavir for Hepatocellular Carcinoma Prevention in an International Consortium of Chronic Hepatitis B
11个月前
已完结
Real‐life impact of tenofovir disoproxil fumarate and entecavir therapy on lipid profile, glucose, and uric acid in chronic hepatitis B patients
11个月前
已完结
Changes in blood lipids in patients with chronic hepatitis B after 48 weeks of tenofovir alafenamide treatment: A prospective real-world clinical study
11个月前
已关闭
Efficacy of entecavir, tenofovir disoproxil fumarate, and tenofovir alafenamide in treatment-naive hepatitis B patients
11个月前
已完结
Serum HBV RNA is associated with liver fibrosis regression in HBeAg ‐positive chronic hepatitis B patients treated with nucleos(t)ide analogues
11个月前
已完结
Sex differences in treatment response to nucleos(t)ide therapy in chronic hepatitis B: a multicenter longitudinal study
11个月前
已完结
High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapy
11个月前
已完结
皖公网安备34019202002308
